ETH News

Whether or not patients will respond to a drug can be determined in advance. In this way, side effects can be avoided and patients benefit, writes Ernst Hafen.

Obtaining relevant patient data for pharmaceutical and medical research in Europe is no easy task. Ernst Hafen outlines a possible way forward.

Education will be digitised, with data connected in a meaningful way and managed by students to inform their learning. Ernst Hafen envisages how his granddaughter will study at ETH and how schools could work with the Swiss Radio and Television Company SRG.

Ernst Hafen argues that society and research will benefit when we have control of our personal health data and manage this data cooperatively.

Ernst Hafen is convinced that new teaching methods will make it easier for students to learn relevant skills. He helped to develop the new course in medicine at ETH.